Select publications

Baum M. The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment. Eur J Cancer 2002;38(15):1984-6. Abstract

Baum M et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002;359(9324):2131-9. Abstract

Baum M et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 2003;98(9):1802-10. Abstract

Buzdar AU; ATAC Trialists' Group. 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer efficacy overview. J Steroid Biochem Mol Biol 2003;86(3-5):399-403. Abstract

Dowsett M, on Behalf of the ATAC Trialists' Group. Analysis of time to recurrence in the ATAC (arimidex, tamoxifen, alone or in combination) trial according to estrogen receptor and progesterone receptor status. Breast Cancer Res Treat 2003;Abstract 4.

Duffy S et al. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. BJOG 2003;110(12):1099-106. Abstract

Duffy SR, Greenwood M. The endometrial cancer data from the ATAC (arimidex, tamoxifen, alone or in combination) trial indicates a protective effect of anastrozole (arimidex) upon the endometrium. Breast Cancer Res Treat 2003; Abstract 134.

Howell A, on Behalf of the ATAC Trialists' Group. Effect of anastrozole on bone mineral density: 2-year results of the arimidex (anastrozole), tamoxifen, alone or in combination (ATAC) trial. Breast Cancer Res Treat 2003;Abstract 129.

Winer EP et al. American Society of Clinical Oncology Technology Assessment Working Group Update: use of aromatase inhibitors in the adjuvant setting. J Clin Oncol 2003;21(13):2597-9. Abstract